Tomi Sawyer
Chief Drug Hunter & President Maestro Therapeutics
Tomi is an entrepreneurial drug hunter with >40 years of industrial experience in both large pharma and biotech. He has three marketed drugs and >670 scientific publications, patents, and presentations (primarily focused on peptide drug discovery). Tomi is the Founding President of the Peptide Drug Hunting Consortium.
Seminars
Wednesday 29th April 2026
Peptide Industry Leaders’ Discussion – Unlocking Next Frontiers of Bioavailable Peptide-Based Therapeutics to Patients Faster
9:15 am
This your chance to hear from pioneering executive leaders the peptide space who will discuss their ambitions, strategies and challenges for peptide discovery, targets. indications and development of next generation of peptide drugs.
Key questions to be addressed include:
- What are the future opportunities, promising targets and applications on the horizon for peptide-drugs to achieve the next best in-market approval?
- Where is the next big wave heading after GLP-1 peptides?
- How will peptide-drugs compete against the biologics, antibody and small molecule markets as standards of care?
Wednesday 29th April 2026
Peptide Drug Hunting: Innovative Science & Technology Empowering Breakthrough Medicines
12:00 pm
- Unveiling recent milestones in peptide drug discovery
- Boosting innovative R&D platforms from design to delivery
- Looking into the future challenges and opportunities
